+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cardiovascular Implants Market by Type, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6010720
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cardiovascular Implants Market grew from USD 33.26 billion in 2023 to USD 35.30 billion in 2024. It is expected to continue growing at a CAGR of 6.21%, reaching USD 50.72 billion by 2030.

The market for cardiovascular implants encompasses a range of medical devices, including stents, pacemakers, heart valves, and ventricular assist devices, designed to treat cardiovascular diseases. These devices are essential for extending patient lifespan and improving quality of life. Their applications include the management and treatment of heart failure, arrhythmias, and other cardiovascular disorders. End-users primarily consist of hospitals, specialty cardiac clinics, and research institutions. Market insights reveal that rising incidences of cardiovascular diseases, an aging population, and advancements in technology substantially drive growth. For instance, the development of bioresorbable stents and leadless pacemakers highlights key innovations set to propel the market forward. However, challenges such as stringent regulatory approval processes, high costs, and the potential for post-surgical complications limit their widespread adoption. Moreover, the market faces hurdles like intense competition and the necessity of continuous technological advancement to combat obsolescence. Yet, increasing healthcare investment in emerging regions presents significant opportunities for expansion. Companies with the agility to adapt to regional regulatory landscapes and patient demographic needs are positioned to capitalize on these growth scenarios. Recommendations include investing in research on materials that improve biocompatibility and longevity of implants, and focusing on minimally invasive implantation techniques, which enhance patient outcomes and recovery times. Further, leveraging artificial intelligence and data analytics could enhance patient monitoring and tailor individualized treatment plans, opening new frontiers in personalized medicine. The nature of the cardiovascular implant market is characterized by rapid innovation cycles and a strong emphasis on research and development. Continuous collaboration with healthcare providers and regulatory bodies to streamline approval processes and reduce costs is essential. Therefore, areas such as smart implantables that integrate digital health technologies and exploring emerging markets offer fertile ground for ongoing innovation and business expansion.

Understanding Market Dynamics in the Cardiovascular Implants Market

The Cardiovascular Implants Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing health consciousness and growing occurrences of cardiovascular disorders
    • Favorable reimbursement policies by government agencies
    • Improved efficacy and safety of cardiovascular implants
  • Market Restraints
    • Strict approval process and high cost of devices
  • Market Opportunities
    • 3D printing of implants and development of medical Biopolymers and biomaterials
    • Development of smart cardiovascular implants
  • Market Challenges
    • Complicated implant design, biofunctionalization, and process development

Exploring Porter’s Five Forces for the Cardiovascular Implants Market

Porter’s Five Forces framework further strengthens the insights of the Cardiovascular Implants Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cardiovascular Implants Market

External macro-environmental factors deeply influence the performance of the Cardiovascular Implants Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cardiovascular Implants Market

The Cardiovascular Implants Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cardiovascular Implants Market

The Cardiovascular Implants Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cardiovascular Implants Market

The Cardiovascular Implants Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Implants Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Artivion, Inc., B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cardiac Implants, LLC, Edwards Lifesciences Corporation, Johnson & Johnson Services, Inc., LivaNova PLC, Medtronic PLC, Neovasc Inc., Sorin Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Implants Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Cardiac Resynchronization Therapy Device
    • Coronary Stents
    • Heart Valves
    • Implantable Cardioverter Defibrillator
    • Implanted Cardiac Pacemakers
    • Peripheral Stents
  • End-User
    • Cardiac Care Centers
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing health consciousness and growing occurrences of cardiovascular disorders
5.1.1.2. Favorable reimbursement policies by government agencies
5.1.1.3. Improved efficacy and safety of cardiovascular implants
5.1.2. Restraints
5.1.2.1. Strict approval process and high cost of devices
5.1.3. Opportunities
5.1.3.1. 3D printing of implants and development of medical Biopolymers and biomaterials
5.1.3.2. Development of smart cardiovascular implants
5.1.4. Challenges
5.1.4.1. Complicated implant design, biofunctionalization, and process development
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cardiovascular Implants Market, by Type
6.1. Introduction
6.2. Cardiac Resynchronization Therapy Device
6.3. Coronary Stents
6.4. Heart Valves
6.5. Implantable Cardioverter Defibrillator
6.6. Implanted Cardiac Pacemakers
6.7. Peripheral Stents
7. Cardiovascular Implants Market, by End-User
7.1. Introduction
7.2. Cardiac Care Centers
7.3. Hospitals
7.4. Specialty Clinics
8. Americas Cardiovascular Implants Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Cardiovascular Implants Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Cardiovascular Implants Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. CARDIOVASCULAR IMPLANTS MARKET RESEARCH PROCESS
FIGURE 2. CARDIOVASCULAR IMPLANTS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. CARDIOVASCULAR IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. CARDIOVASCULAR IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. CARDIOVASCULAR IMPLANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CARDIOVASCULAR IMPLANTS MARKET DYNAMICS
TABLE 7. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CORONARY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTED CARDIAC PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CARDIAC CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 32. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. AUSTRALIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. AUSTRALIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. CHINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. CHINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. INDIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. INDIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. INDONESIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. INDONESIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. JAPAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. JAPAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. MALAYSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. MALAYSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. PHILIPPINES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. PHILIPPINES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. SINGAPORE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. SINGAPORE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. SOUTH KOREA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. SOUTH KOREA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. TAIWAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. TAIWAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. THAILAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. THAILAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. VIETNAM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. VIETNAM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. DENMARK CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. DENMARK CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. EGYPT CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. EGYPT CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. FINLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. FINLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. ISRAEL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. ISRAEL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. NETHERLANDS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. NETHERLANDS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. NIGERIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. NIGERIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. NORWAY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. NORWAY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. POLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. POLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. QATAR CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. QATAR CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. SWEDEN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. SWEDEN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. SWITZERLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. SWITZERLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. TURKEY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. TURKEY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. CARDIOVASCULAR IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 105. CARDIOVASCULAR IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Cardiovascular Implants market, which are profiled in this report, include:
  • Abbott Laboratories
  • Artivion, Inc.
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Implants, LLC
  • Edwards Lifesciences Corporation
  • Johnson & Johnson Services, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • Neovasc Inc.
  • Sorin Corporation
  • Terumo Corporation

Methodology

Loading
LOADING...

Table Information